UPMC Hillman
Pittsburgh, PA
Delegate Rep: Amanda Henson
Website: https://hillman.upmc.com/
Help shape the future of Oncology Issues by serving on the journal’s Editorial Board. ACCC is seeking members interested in contributing to editorial priorities, authoring articles, facilitating guest contributors from their cancer programs, and peer reviewing submissions. Board members also help identify timely topics and bring diverse perspectives from across the multidisciplinary cancer care community.
Interested in serving? Contact Rania Emara, Managing Editor, at remara@accc-cancer.org to learn more.
The ACCC Oncology Reimbursement Meetings (ORMs) are a free resource designed to help ACCC members navigate the annual changes in oncology reimbursement and regulations, provide tools to strengthen program operations, and accelerate knowledge on which measures can be taken now to succeed in this rapidly changing landscape.
This fall, attendees will hear from experts on the state of oncology financial navigation, how to address gaps in financial assistance, policy developments related to the “lawfully present” population, and more. New this year, attendees will also have the chance to participate in a networking reception following the final session to connect with local colleagues and share insights from the meeting.
November 4, 2026
Whitney Peak Hotel Reno
Reno, NV
REGISTER NOW
VIEW AGENDA
November 10, 2026
Renaissance Providence Downtown Hotel
Providence, RI
REGISTER NOW
VIEW AGENDA
Epidermal growth factor receptor inhibitor therapies are a valuable tool in cancer care; however, these therapies come with challenging adverse events (AEs), most notably dermatologic toxicities. These AEs can significantly impact quality of life and require coordinated, interdisciplinary management informed by a deep understanding of the patient’s experience.
ACCC brought together a diverse group of experts, including patient advocates and providers across the multidisciplinary care team, for a three-part webinar series covering:
Explore how cancer centers can support hereditary cancer prevention beyond traditional oncology settings and ensure equitable screening with this on-demand webinar. Faculty from University of Illinois Cancer Center share implementation insights on:
Care for patients with relapsed/refractory follicular lymphoma is becoming increasingly complex, with evolving treatment options, individualized sequencing decisions, and growing demands for coordinated, patient-centered care. Drawing on a national landscape analysis, this effective practices guide offers practical strategies to help cancer programs strengthen care delivery across the oncology continuum.
